• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Best model of hypermobility to explain the spectrum

Pyrrhus

Pyrrhus

Senior Member
Messages
4,172
Location
U.S., Earth
Nasaud said:
Hi everyone,

Doctor Marco Castori a Italian Connective Tissue Disorder specialist wrote this paper which I think explains all the possible phenotypes of connective tissue disorders and how to approach them and study them. This is just a model, but in time it may shed some light on how to understand better this condition.

https://pubmed.ncbi.nlm.nih.gov/33668066/
Click to expand...

Abstract:
Castori 2021 said:
Deconstructing and reconstructing joint hypermobility on an evo-devo perspective (Castori, 2021)

Joint hypermobility is a common characteristic in humans. Its non-casual association with various musculoskeletal complaints is known and currently defined "the spectrum". It includes hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD).

hEDS is recognized by a set of descriptive criteria, while HSD is the background diagnosis for individuals not fulfilling these criteria. Little is known about the aetiopathogenesis of the spectrum. It may be interpreted as a complex trait according to the integration model. Particularly, the spectrum is common in the general population, affects morphology, presents extreme clinical variability and is characterized by marked sex bias without a clear Mendelian or hormonal explanation.

Joint hypermobility and the other hEDS systemic criteria are intended as qualitative derivatives of continuous traits of normal morphological variability. The need for a minimum set of criteria for hEDS diagnosis implies a tendency to co-vary of these underlying continuous traits. In evolutionary biology, such a co-variation (i.e. integration) is driven by multiple forces, including genetic, developmental, functional and environmental/acquired interactors. The aetiopathogenesis of the spectrum may be resolved by a deeper understanding of phenotypic variability, which superimposes on normal morphological variability.
Click to expand...
 
You must log in or register to reply here.